Literature DB >> 16594427

Complementary and alternative medicine in breast cancer patients.

Zeina Nahleh1, Imad A Tabbara.   

Abstract

OBJECTIVE: Complementary and Alternative Medicine (CAM) is becoming increasingly popular among cancer patients, in particular those with breast cancer. It represents one of the fastest growing treatment modalities in the United States. Therefore, knowledge of CAM therapies is becoming necessary for physicians and other health care providers. CAM encompasses a wide range of modalities including special diet and nutrition, mind-body approaches, and traditional Chinese medicine.
METHODS: We reviewed the biomedical literature on CAM use in breast cancer patients, using Medline search from 1975 until 2002. In addition, consensus reports and books on CAM and breast cancer were included in the review. We evaluated the prevalence of CAM use in breast cancer patients, the reasons cited for its use, the different available modalities, and the reported outcomes.
RESULTS: Use of CAM in breast cancer patients ranges between 48% and 70% in the United States. The most commonly used CAM modalities include dietary supplements, mind-body approaches, and acupuncture. The reasons cited for using CAM were to boost the immune system, improve the quality of life, prevent recurrence of cancer, provide control over life, and treat breast cancer and the side effects of treatment. Several studies reported favorable results including improved survival, better pain control, reduced anxiety, improvement in coping strategies and significant efficacy in treating nausea and vomiting. Other less well-organized trials have reported either no benefit or negative effect of CAM and potential toxicity of some commercial products. SIGNIFICANCE OF
RESULTS: CAM is a growing field in health care and particularly among breast cancer patients. Knowledge of CAM by physicians, especially oncologists, is necessary. Oncologists should be willing to discuss the role of CAM with their patients and encourage patients to participate in well-organized research about CAM.

Entities:  

Mesh:

Year:  2003        PMID: 16594427     DOI: 10.1017/s1478951503030256

Source DB:  PubMed          Journal:  Palliat Support Care        ISSN: 1478-9515


  24 in total

1.  Perceptions and use of complementary and alternative medicine in American Samoa: a survey of health care providers.

Authors:  Sara L Krosch
Journal:  Hawaii Med J       Date:  2010-06

2.  A comparative study of complementary and alternative medicine use among heterosexually and lesbian identified women: data from the ESTHER Project (Pittsburgh, PA, 2003-2006).

Authors:  Helen A Smith; Alicia Matthews; Nina Markovic; Ada Youk; Michelle E Danielson; Evelyn O Talbott
Journal:  J Altern Complement Med       Date:  2010-11       Impact factor: 2.579

3.  Can we demonstrate that breast cancer "integrative oncology" is effective? A methodology to evaluate the effectiveness of integrative oncology offered in community clinics.

Authors:  Leanna J Standish; Erin Sweet; Eleonora Naydis; M Robyn Andersen
Journal:  Integr Cancer Ther       Date:  2012-06-27       Impact factor: 3.279

Review 4.  Clinical practice guidelines on the use of integrative therapies as supportive care in patients treated for breast cancer.

Authors:  Heather Greenlee; Lynda G Balneaves; Linda E Carlson; Misha Cohen; Gary Deng; Dawn Hershman; Matthew Mumber; Jane Perlmutter; Dugald Seely; Ananda Sen; Suzanna M Zick; Debu Tripathy
Journal:  J Natl Cancer Inst Monogr       Date:  2014-11

5.  Medicinal mushroom Phellinus linteus as an alternative cancer therapy.

Authors:  Daniel Sliva
Journal:  Exp Ther Med       Date:  2010-05-01       Impact factor: 2.447

6.  Scope of symptoms and self-management strategies for chemotherapy-induced peripheral neuropathy in breast cancer patients.

Authors:  Rebecca M Speck; Angela DeMichele; John T Farrar; Sean Hennessy; Jun J Mao; Margaret G Stineman; Frances K Barg
Journal:  Support Care Cancer       Date:  2012-01-11       Impact factor: 3.603

7.  Complementary and alternative medicine use and breast cancer prognosis: a pooled analysis of four population-based studies of breast cancer survivors.

Authors:  Rayna Kim Matsuno; Ian S Pagano; Gertraud Maskarinec; Brian F Issell; Carolyn C Gotay
Journal:  J Womens Health (Larchmt)       Date:  2012-10-17       Impact factor: 2.681

8.  Use of complementary and alternative medicine in inner-city persons with or at risk for HIV infection.

Authors:  Felise B Milan; Julia H Arnsten; Robert S Klein; Ellie E Schoenbaum; Galina Moskaleva; Donna Buono; Mayris P Webber
Journal:  AIDS Patient Care STDS       Date:  2008-10       Impact factor: 5.078

9.  Prognosis following the use of complementary and alternative medicine in women diagnosed with breast cancer.

Authors:  Juliann Saquib; Barbara A Parker; Loki Natarajan; Lisa Madlensky; Nazmus Saquib; Ruth E Patterson; Vicky A Newman; John P Pierce
Journal:  Complement Ther Med       Date:  2012-04-27       Impact factor: 2.446

10.  Pancreatic proteolytic enzyme therapy compared with gemcitabine-based chemotherapy for the treatment of pancreatic cancer.

Authors:  John A Chabot; Wei-Yann Tsai; Robert L Fine; Chunxia Chen; Carolyn K Kumah; Karen A Antman; Victor R Grann
Journal:  J Clin Oncol       Date:  2009-08-17       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.